Results
NATCO Pharma Q2 FY27 Earnings Call Transcript
NATCO reported Q2 FY27 consolidated revenue of ₹1,019.4 crore, down YoY due to lower lenalidomide sales but up QoQ on strong international performance.
The company acquired an additional 13.25% stake